Published September 6, 2022
| Version v2022-09-06
Software
Open
monarch-initiative/mondo: v2022-09-06
Creators
- Nicole Vasilevsky
- Chris Mungall1
- Nico Matentzoglu2
- sabrinatoro
- kallia-p
- Lauren
- Shahim Essaid
- bbopjenkins
- Harshad1
- Joe Flack3
- actions-user4
- Emily Hartley5
- Ray Stefancsik
- Eric Douglass
- Daniel Himmelstein6
- Deepak7
- Jim Balhoff8
- Daniel-Olson
- Tiffany J. Callahan9
- Benjamin M. Gyori10
- Charles Tapley Hoyt10
- Julie McMurry11
- Kevin Schaper
- Larry Babb
- Monica Munoz-Torres12
- Shawn Tan
- sagehrke13
- 1. Lawrence Berkeley National Laboratory
- 2. semanticly Ltd
- 3. @TB-Modeling
- 4. @actions
- 5. Critical Path Institute
- 6. @related-sciences
- 7. SIB Swiss Institute of Bioinformatics
- 8. @RENCI
- 9. Columbia University
- 10. Harvard Medical School
- 11. tislab.org
- 12. TISLab, CU
- 13. University of Colorado
Description
Overview:
- Number of new terms: 19
- Number of changed labels: 15
- Number of changed definitions: 70
- Number obsoleted terms: 42
- Number of new obsoletion candidates: 5
- Number of terms who were previously candidate for obsoletion and are now not anymore: 43
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100434 | chronic mountain sickness | A pathological condition resulting from chronic exposure to hypoxia at high altitude. The syndrome is characterized by an excessive number of red blood cells associated with a high blood hemoglobin concentration ([Hb]), hypoxemia, and, in some cases, pulmonary hypertension. Clinical signs include headache, fatigue, sleep disturbances, dyspnea, digestive complaints, and high risk of thrombotic events. |
MONDO:0100440 | Asperger syndrome, susceptibility to | An inherited susceptibility or predisposition to developing Asperger sydrome. |
MONDO:0100473 | disorder of peptide and amine metabolism | An inherited metabolic disease that has its basis in the disruption of peptide and/or amine metabolic process. |
MONDO:0100477 | disorder of methylamine metabolism | An inherited metabolic disease that has its basis in the disruption of methylamine metabolic process. |
MONDO:0100509 | IFT140-related recessive ciliopathy | Any ciliopathy in which the cause of the disease is biallelic variants in the IFT140 gene. |
MONDO:0100510 | spondyloepimetaphyseal dysplasia | An osteochondrodysplasia that results in abnormalities of bone growth in the vertebral column, epiphysis, and metaphysis. |
MONDO:0100514 | familial ovarian carcinoma | Ovarian carcinoma that has developed in relatives of patients that have a history of ovarian carcinoma. |
MONDO:0100515 | mirror movements 1 and/or agenesis of the corpus callosum | A familial congenital mirror movement disorder where individuals with heterozygous variants in DCC have congenital mirror movements and/or agenesis of the corpus callosum (not with or without- some individuals do not demonstrate mirror movements and only have corpus callosum defects, even within the same family). |
MONDO:0100516 | complex neurodevelopmental disorder with motor features | A complex neurodevelopmental disorder that involves more than one phenotype associated with the central nervous system, including but not limited to intellectual disability, autism, and seizures (epilepsy). Additionally, the disorder features at least one phenotype associated with motor function, including but not limited to spasticity, hypo- or hypertonia, dyskinesia, choreo-athetosis, or ataxia. |
MONDO:0800107 | anterior deviation infundibular septum | |
MONDO:0800108 | cleft leaflet of tricuspid valve | |
MONDO:0800152 | disorder of galactose and fructose metabolism | An inherited disorder of carbohydrate metabolism that is has its basis in the disruption of galactose and/or fructose metabolic process. |
MONDO:0800153 | urea cycle disorder or inherited hyperammonemia | A disorder of amino acid metabolism that has its basis in the disruption of the urea cycle and/or there is an inherited increased concentration of ammonia in the blood. |
MONDO:0800154 | inborn disorder of the metabolism of sulfur-containing amino acids and hydrogen sulfide | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of sulfur-containing amino acids and/or hydrogen sulfide. |
MONDO:0800155 | inborn disorder of glycine and serine metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of glycine and/or serine. |
MONDO:0800156 | inborn disorder of ornithine, proline and hydroxyproline metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of ornithine, proline and/or hydroxyproline. |
MONDO:0800157 | inborn disorder of lysine, hydroxylysine, and tryptophan metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of lysine, hydroxylysine, and/or tryptophan. |
MONDO:0800158 | inborn disorder of glutamate/glutamine and aspartate/asparagine metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of glutamate/glutamine and aspartate/asparagine. |
MONDO:0800159 | disorder of polyamine metabolism | An inherited metabolic disease that has its basis in the disruption of the polyamine metabolic process. |
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0004736 | inborn disorder of amino acid metabolism | inherited amino acid metabolic disorder | inborn disorder of amino acid metabolism |
MONDO:0000688 | inborn organic aciduria | inherited organic acidemia | inborn organic aciduria |
MONDO:0002412 | disorder of glycogen metabolism | glycogen storage disease | disorder of glycogen metabolism |
MONDO:0019216 | inborn disorder of amino acid transport | inborn disorder of amino acid absorption and transport | inborn disorder of amino acid transport |
MONDO:0017706 | disorder of carbohydrate transmembrane transport and absorption | disorder of carbohydrate absorption and transport | disorder of carbohydrate transmembrane transport and absorption |
MONDO:0019225 | disorder of gluconeogenesis | gluconeogenesis disorder | disorder of gluconeogenesis |
MONDO:0010078 | spondyloperipheral dysplasia | spondyloperipheral dysplasia-short ulna syndrome | spondyloperipheral dysplasia |
MONDO:0010888 | adenomyosis | endometriosis of uterus | adenomyosis |
MONDO:0016200 | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase - | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
MONDO:0014502 | Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency |
MONDO:0016182 | qualitative or quantitative defects of protein O-mannose beta1, 2N-acetylglucosaminyltransferase | qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase | qualitative or quantitative defects of protein O-mannose beta1, 2N-acetylglucosaminyltransferase |
MONDO:0016454 | Charcot-Marie-Tooth disease type 2B5 | severe early-onset axonal neuropathy due to NEFL deficiency | Charcot-Marie-Tooth disease type 2B5 |
MONDO:0019235 | inborn disorder of phenylalanine and tyrosine metabolism | inborn disorder of phenylalanin or tyrosine metabolism | inborn disorder of phenylalanine and tyrosine metabolism |
MONDO:0019223 | disorder of fatty acid and ketone body metabolism | inborn disorder of fatty acid oxidation and ketone body metabolism | disorder of fatty acid and ketone body metabolism |
MONDO:0017900 | autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency | autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency | autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency |
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0000155 | triglyceride storage disease | An acquired metabolic disease that is has its basis in the disruption of sequestering of triglyceride. | An inherited metabolic disease that is has its basis in the disruption of sequestering of triglyceride. |
MONDO:0019226 | glucose transport disorder | An acquired metabolic disease that is has its basis in the disruption of glucose transport. | An inherited metabolic disease that is has its basis in the disruption of glucose transport. |
MONDO:0000273 | Kunjin virus infectous disease | A West Nile encephalitis that results in infection located in brain, has material basis in Kunjin virus, a subtype of West Nile Virus, which is transmitted by Culex annulirostris mosquito bite. The infection has symptom fever, has symptom rigor, has symptom headache, has symptom confusion, and has symptom lethargy. | |
MONDO:0000351 | disorder of methionine catabolism | An acquired metabolic disease that is has its basis in the disruption of methionine catabolic process. | An inherited metabolic disease that is has its basis in the disruption of methionine catabolic process. |
MONDO:0019222 | inborn disorder of methionine cycle and sulfur amino acid metabolism | An acquired metabolic disease that is has its basis in the disruption of sulfur amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of sulfur amino acid metabolic process. |
MONDO:0037938 | inborn disorder of aspartate family metabolism | An acquired metabolic disease that is has its basis in the disruption of aspartate family amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of aspartate family amino acid metabolic process. |
MONDO:0000421 | inborn serine deficiency | An acquired metabolic disease that is has its basis in the disruption of L-serine biosynthetic process. | An inherited metabolic disease that is has its basis in the disruption of L-serine biosynthetic process. |
MONDO:0019239 | inborn disorder of serine family metabolism | An acquired metabolic disease that is has its basis in the disruption of serine family amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of serine family amino acid metabolic process. |
MONDO:0005528 | inborn vitamin metabolic disorder | An acquired metabolic disease that is has its basis in the disruption of vitamin metabolic process. | An inherited metabolic disease that is has its basis in the disruption of vitamin metabolic process. |
MONDO:0019243 | inborn disorder of energy metabolism | An acquired metabolic disease that is has its basis in the disruption of generation of precursor metabolites and energy. | An inherited metabolic disease that is has its basis in the disruption of generation of precursor metabolites and energy. |
MONDO:0019224 | inborn disorder of gamma-aminobutyric acid metabolism | An acquired metabolic disease that is has its basis in the disruption of gamma-aminobutyric acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of gamma-aminobutyric acid metabolic process. |
MONDO:0045046 | inherited thyroid metabolism disease | An acquired metabolic disease that is has its basis in the disruption of thyroid hormone metabolic process. | An inherited metabolic disease that is has its basis in the disruption of thyroid hormone metabolic process. |
MONDO:0019214 | inborn carbohydrate metabolic disorder | An acquired metabolic disease that is has its basis in the disruption of carbohydrate metabolic process. | An inherited metabolic disease that is has its basis in the disruption of carbohydrate metabolic process. |
MONDO:0019236 | inborn disorder of purine metabolism | An acquired metabolic disease that is has its basis in the disruption of purine nucleobase metabolic process. | An inherited metabolic disease that is has its basis in the disruption of purine nucleobase metabolic process. |
MONDO:0016789 | pyruvate metabolism disorder | An acquired metabolic disease that is has its basis in the disruption of pyruvate metabolic process. | An inherited metabolic disease that is has its basis in the disruption of pyruvate metabolic process. |
MONDO:0017762 | disorder of copper metabolism | An acquired metabolic disease that is has its basis in the disruption of cellular copper ion homeostasis. | An inherited metabolic disease that is has its basis in the disruption of cellular copper ion homeostasis. |
MONDO:0007481 | Leri-Weill dyschondrosteosis | LC)ri-Weill dyschondrosteosis (LWD) is a skeletal dysplasia marked by disproportionate short stature and the characteristic Madelung wrist deformity. | Leri-Weill dyschondrosteosis (LWD) is a skeletal dysplasia marked by disproportionate short stature and the characteristic Madelung wrist deformity. |
MONDO:0007646 | Gamstorp-Wohlfart syndrome | Autosomal recessive axonal neuropathy with neuromyotonia is a rare peripheral neuropathy characterized by slowly progressive axonal, motor greater than sensory polyneuropathy combined with neuromytonia (including spontaneous muscular activity at rest (myokymia), impaired muscle relaxation (pseudomyotonia), and contractures of hands and feet) and neuromyotonic or myokymic discharges on needle EMG. It presents with distal lower limb weakness with gait impairment, muscle stiffness, fasciculations and cramps in hands and legs worsened by cold, decreased to absent tendon reflexes, intrinsic hand muscle atrophy and, variably, mild distal sensory impairment. | A rare peripheral neuropathy characterized by slowly progressive axonal, motor greater than sensory polyneuropathy combined with neuromytonia (including spontaneous muscular activity at rest (myokymia), impaired muscle relaxation (pseudomyotonia), and contractures of hands and feet) and neuromyotonic or myokymic discharges on needle EMG. It presents with distal lower limb weakness with gait impairment, muscle stiffness, fasciculations and cramps in hands and legs worsened by cold, decreased to absent tendon reflexes, intrinsic hand muscle atrophy and, variably, mild distal sensory impairment. |
MONDO:0007921 | yellow nail syndrome | Yellow nail syndrome (YNS) is a very rare syndromic disorder characterized by the variable triad of characteristic yellow nails, chronic respiratory manifestations, and primary lymphedema. | A very rare syndromic disorder characterized by the variable triad of characteristic yellow nails, chronic respiratory manifestations, and primary lymphedema. |
MONDO:0008469 | spondyloepimetaphyseal dysplasia-hypotrichosis syndrome | Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome is a rare primary bone dysplasia disorder characterized by congenital hypotrichosis associated with rhizomelic short stature (more pronounced in upper limbs than lower limbs), limited hip abduction and mild genu varum. Flared and irregular metaphyses, delayed and irregular epiphiseal ossification and pear-shaped vertebral bodies are characteristic radiologic findings. | A rare primary bone dysplasia disorder characterized by congenital hypotrichosis associated with rhizomelic short stature (more pronounced in upper limbs than lower limbs), limited hip abduction and mild genu varum. Flared and irregular metaphyses, delayed and irregular epiphiseal ossification and pear-shaped vertebral bodies are characteristic radiologic findings. |
MONDO:0008471 | spondyloepiphyseal dysplasia congenita | Spondyloepiphyseal dysplasia congenita (SEDC) is a chondrodysplasia characterized by disproportionate short stature, abnormal epiphyses and flattened vertebral bodies. | A chondrodysplasia characterized by disproportionate short stature, abnormal epiphyses and flattened vertebral bodies. |
MONDO:0008476 | spondyloepimetaphyseal dysplasia, Strudwick type | Spondyloepimetaphyseal dysplasia congenita, Strudwick type is characterized by disproportionate short stature from birth (with a very short trunk and shortened limbs) and skeletal abnormalities (lordosis, scoliosis, flattened vertebrae, pectus carinatum, coxa vara, clubfoot, and abnormal epiphyses or metaphyses). | A spondyloepimetaphyseal dysplasia characterized by disproportionate short stature from birth (with a very short trunk and shortened limbs) and skeletal abnormalities (lordosis, scoliosis, flattened vertebrae, pectus carinatum, coxa vara, clubfoot, and abnormal epiphyses or metaphyses). |
MONDO:0016790 | tricarboxylic acid cycle disorder | An acquired metabolic disease that is has its basis in the disruption of tricarboxylic acid cycle. | An inherited metabolic disease that is has its basis in the disruption of tricarboxylic acid cycle. |
MONDO:0019229 | inborn disorder of ketolysis | An acquired metabolic disease that is has its basis in the disruption of ketone body catabolic process. | An inherited metabolic disease that is has its basis in the disruption of ketone body catabolic process. |
MONDO:0008858 | Behr syndrome | Behr syndrome is a disorder characterized by early-onset optic atrophy along with neurological features, including ataxia, spasticity, and intellectual disability. Other signs and symptoms may be present and vary from person to person. This condition is caused by mutations in the OPA1 gene. It is inherited in an autosomal recessive manner. Treatment depends on the specific signs and symptoms seen in the patient. | A disorder characterized by early-onset optic atrophy along with neurological features, including ataxia, spasticity, and intellectual disability. Other signs and symptoms may be present and vary from person to person. This condition is caused by mutations in the OPA1 gene. It is inherited in an autosomal recessive manner. Treatment depends on the specific signs and symptoms seen in the patient. |
MONDO:0019240 | sterol biosynthesis disorder | An acquired metabolic disease that is has its basis in the disruption of sterol biosynthetic process. | An inherited metabolic disease that is has its basis in the disruption of sterol biosynthetic process. |
MONDO:0009196 | ermine phenotype | Cutaneous albinism-ermine phenotype is characterised by the association of white hair with black tufts, depigmented skin and sensorineural deafness. It has been described in two pairs of siblings and one individual case. The depigmentation may present as vitiligo, or be spotted with brown patches. Nystagmus, photophobia, retinal depigmentation and intellectual deficit were also reported in one pair of siblings. An autoimmune mechanism or failure of melanocyte migration may be responsible for the disease. | A rare deafness characterized by the association of bilateral sensorineural hearing loss and white hair with scattered black tufts, as well as skin areas of hyper- and hypopigmentation. Additional reported features include global developmental delay and moderate intellectual disability, growth retardation, microcephaly, hypotonia, mild dysmorphic facial features (deeply set eyes, broad nasal bridge, slight bowing of the upper lip), retinal depigmentation, anomalies of the fingers and toes, and white matter abnormalities on brain imaging. |
MONDO:0019225 | disorder of gluconeogenesis | An acquired metabolic disease that is has its basis in the disruption of gluconeogenesis. | An inherited metabolic disease that is has its basis in the disruption of gluconeogenesis. |
MONDO:0040566 | inherited glutathione metabolism disease | An acquired metabolic disease that is has its basis in the disruption of glutathione metabolic process. | An inherited metabolic disease that is has its basis in the disruption of glutathione metabolic process. |
MONDO:0017687 | disorder of neutral amino acid transport | An acquired metabolic disease that is has its basis in the disruption of neutral amino acid transport. | An inherited metabolic disease that is has its basis in the disruption of neutral amino acid transport. |
MONDO:0019228 | inborn disorder of histidine metabolism | An acquired metabolic disease that is has its basis in the disruption of histidine metabolic process. | An inherited metabolic disease that is has its basis in the disruption of histidine metabolic process. |
MONDO:0019242 | inborn disorder of branched-chain amino acid metabolism | An acquired metabolic disease that is has its basis in the disruption of branched-chain amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of branched-chain amino acid metabolic process. |
MONDO:0017350 | inborn disorder of tryptophan metabolism | An acquired metabolic disease that is has its basis in the disruption of tryptophan metabolic process. | An inherited metabolic disease that is has its basis in the disruption of tryptophan metabolic process. |
MONDO:0009393 | ornithine translocase deficiency | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (triple H syndrome) is a disorder of urea cycle metabolism characterized by either a neonatal-onset with manifestations of lethargy, poor feeding, vomiting and tachypnea or, more commonly, presentations in infancy, childhood or adulthood with chronic neurocognitive deficits, acute encephalopathy and/or chronic liver dysfunction. | A rare, genetic disorder of urea cycle metabolism characterized by either a neonatal-onset with manifestations of lethargy, poor feeding, vomiting and tachypnea or, more commonly, presentations in infancy, childhood or adulthood with chronic neurocognitive deficits, acute encephalopathy and/or coagulation defects or other chronic liver dysfunction. |
MONDO:0018424 | inherited lipoic acid biosynthesis defect | An acquired metabolic disease that is has its basis in the disruption of lipoate biosynthetic process. | An inherited metabolic disease that is has its basis in the disruption of lipoate biosynthetic process. |
MONDO:0009579 | Frank-Ter Haar syndrome | Frank-ter Haar syndrome (formerly considered as an autosomal recessive form of Melnick-Needles syndrome) is defined by megalocornea, multiple skeletal anomalies, characteristic facial dysmorphism (wide fontanels, prominent forehead, hypertelorism, prominent eyes, full cheeks and micrognathia) and developmental delay. | A syndrome defined by megalocornea, multiple skeletal anomalies, characteristic facial dysmorphism (wide fontanels, prominent forehead, hypertelorism, prominent eyes, full cheeks and micrognathia) and developmental delay. |
MONDO:0017356 | inborn disorder of ornithine metabolism | An acquired metabolic disease that is has its basis in the disruption of ornithine metabolic process. | An inherited metabolic disease that is has its basis in the disruption of ornithine metabolic process. |
MONDO:0019237 | inborn disorder of pyridoxine metabolism | An acquired metabolic disease that is has its basis in the disruption of pyridoxine metabolic process. | An inherited metabolic disease that is has its basis in the disruption of pyridoxine metabolic process. |
MONDO:0010076 | spondyloepimetaphyseal dysplasia, Irapa type | Spondyloepimetaphyseal dysplasia, Irapa type is characterized by disproportionate short-trunked short stature, pectus carinatum, short arms, short and broad hands, short metatarsals, flat and broad feet, coxa vara, genu valgum, osteoarthritis, arthrosis and moderate-to-serious gait impairment. | A spondyloepimetaphyseal dysplasia is characterized by disproportionate short-trunked short stature, pectus carinatum, short arms, short and broad hands, short metatarsals, flat and broad feet, coxa vara, genu valgum, osteoarthritis, arthrosis and moderate-to-serious gait impairment. |
MONDO:0010077 | spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome | Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome is a rare, genetic primary bone dysplasia disorder characterized by disproportionate short stature with shortening of upper and lower limbs, short and broad fingers with short hands, narrowed chest with rib abnormalities and pectus excavatum, abnormal chondral calcifications (incl. larynx, trachea and costal cartilages) and facial dysmorphism (frontal bossing, hypertelorism, prominent eyes, short flat nose, wide nostrils, high-arched palate, long philtrum). Platyspondyly (esp. of cervical spine) and abnormal epiphyses and metaphyses are observed on radiography. Atlantoaxial instability causing spinal compression and recurrent respiratory disease are potential complications that may result lethal. | A rare, genetic primary bone dysplasia disorder characterized by disproportionate short stature with shortening of upper and lower limbs, short and broad fingers with short hands, narrowed chest with rib abnormalities and pectus excavatum, abnormal chondral calcifications (incl. larynx, trachea and costal cartilages) and facial dysmorphism (frontal bossing, hypertelorism, prominent eyes, short flat nose, wide nostrils, high-arched palate, long philtrum). Platyspondyly (esp. of cervical spine) and abnormal epiphyses and metaphyses are observed on radiography. Atlantoaxial instability causing spinal compression and recurrent respiratory disease are potential complications that may result lethal. |
MONDO:0010078 | spondyloperipheral dysplasia | An autosomal dominant condition caused by mutation(s) in the COL2A1 gene, encoding collagen alpha-1(II) chain. It is characterized by short stature, pugilistic facies, midface hypoplasia, spondyloepiphyseal dysplasia, kyphosis, short ulna, and absent styloid process. Mutation(s) in the same gene are responsible for Kniest dysplasia. | A condition caused by by truncating mutations in the C-propeptide of COL2A1. Like other type II collagen disorders it is characterised by short stature, platyspondyly and epiphyseal dysplasia. A distinguishing feature is the presence of brachydactyly with a prominent first toe. |
MONDO:0017686 | inborn aminoacylase deficiency | An acquired metabolic disease that is has its basis in the disruption of aminoacylase activity. | An inherited metabolic disease that is has its basis in the disruption of aminoacylase activity. |
MONDO:0010613 | inborn glycerol kinase deficiency | An acquired metabolic disease that is has its basis in the disruption of glycerol kinase activity. | An inherited metabolic disease that is has its basis in the disruption of glycerol kinase activity. |
MONDO:0019227 | inborn disorder of glycerol metabolism | An acquired metabolic disease that is has its basis in the disruption of glycerol metabolic process. | An inherited metabolic disease that is has its basis in the disruption of glycerol metabolic process. |
MONDO:0019256 | sterol metabolism disorder | An acquired metabolic disease that is has its basis in the disruption of sterol metabolic process. | An inherited metabolic disease that is has its basis in the disruption of sterol metabolic process. |
MONDO:0020704 | inherited rippling muscle disease | Rippling muscle disease is a rare, genetic, neuromuscular disorder characterized by muscle hyperirritability triggered by stretch, percussion or movement. Patients present wave-like, electrically-silent muscle contractions (rippling), muscle mounding, painful muscle stiffness and muscle hypertrophy, usually with elevated serum creatine kinase. | A rare, genetic, neuromuscular disorder characterized by muscle hyperirritability triggered by stretch, percussion or movement. Patients present wave-like, electrically-silent muscle contractions (rippling), muscle mounding, painful muscle stiffness and muscle hypertrophy, usually with elevated serum creatine kinase. |
MONDO:0011124 | spondyloepimetaphyseal dysplasia-abnormal dentition syndrome | Spondyloepimetaphyseal dysplasia-abnormal dentition syndrome is a rare primary bone dysplasia disorder characterized by the association of dental anomalies (oligodontia with pointed incisors) and generalized platyspondyly with epiphyseal and metaphyseal involvement. Thin tapering fingers and accentuated palmar creases are additional features. | A rare primary bone dysplasia disorder characterized by the association of dental anomalies (oligodontia with pointed incisors) and generalized platyspondyly with epiphyseal and metaphyseal involvement. Thin tapering fingers and accentuated palmar creases are additional features. |
MONDO:0011198 | spondyloepimetaphyseal dysplasia, Missouri type | Spondyloepimetaphyseal dysplasia, Missouri type is characterized by moderate-to-severe metaphyseal changes, mild epiphyseal involvement, rhizomelic shortening of the lower limbs with bowing of the femora and/or tibiae, coxa vara, genu varum and pear-shaped vertebrae in childhood. | A spondyloepimetaphyseal dysplasia characterized by moderate-to-severe metaphyseal changes, mild epiphyseal involvement, rhizomelic shortening of the lower limbs with bowing of the femora and/or tibiae, coxa vara, genu varum and pear-shaped vertebrae in childhood. |
MONDO:0011252 | spondyloepimetaphyseal dysplasia, Shohat type | Spondyloepimetaphyseal dysplasia congenita, Shohat type is characterized by severely disproportionate short stature, short limbs, small chest, short neck, thin lips, severe lumbar lordosis, marked genu varum, joint laxity, distended abdomen, mild hepatomegaly and splenomegaly. | A spondyloepimetaphyseal dysplasia characterized by severely disproportionate short stature, short limbs, small chest, short neck, thin lips, severe lumbar lordosis, marked genu varum, joint laxity, distended abdomen, mild hepatomegaly and splenomegaly. |
MONDO:0011262 | camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye | Camptodactyly-joint contractures-facial skeletal defects syndrome is characterised by the association of camptodactyly, multiple eye defects (fibrosis of the medial rectus muscle, severe myopia, ptosis and exophthalmos), scoliosis, flexion contractures and facial anomalies (arched eyebrows, facial asymmetry with an abnormal skull shape, a prominent nose, small mouth, low-set and dysplastic ears, and a low nuchal hairline). | A rare multiple congenital anomalies syndrome characterized by the association of camptodactyly, multiple eye defects (fibrosis of the medial rectus muscle, severe myopia, ptosis and exophthalmos), scoliosis, flexion contractures and facial anomalies (arched eyebrows, facial asymmetry with an abnormal skull shape, a prominent nose, small mouth, low-set and dysplastic ears, and a low nuchal hairline). |
MONDO:0012108 | spondyloepimetaphyseal dysplasia, matrilin-3 type | Spondyloepimetaphyseal dysplasia, matrilin-3 type is characterized by disproportionate early-onset dwarfism, bowing of the lower limbs, short, wide and stocky long bones with severe epiphyseal and metaphyseal changes, lumbar lordosis, hypoplastic iliac bones, flat ovoid vertebral bodies and normal hands. | A spondyloepimetaphyseal dysplasia characterized by disproportionate early-onset dwarfism, bowing of the lower limbs, short, wide and stocky long bones with severe epiphyseal and metaphyseal changes, lumbar lordosis, hypoplastic iliac bones, flat ovoid vertebral bodies and normal hands. |
MONDO:0012495 | spondyloepimetaphyseal dysplasia, Genevieve type | Spondyloepimetaphyseal dysplasia, Geneviève type is a rare primary bone dysplasia characterized by severe developmental delay and skeletal dysplasia (including short stature, premature carpal ossification, platyspondyly, longitudinal metaphyseal striations, and small epiphyses), as well as moderate to severe intellectual disability and facial dysmorphism, including prominent forehead, mild synophrys, depressed nasal bridge, prominent bulbous nasal tip and full lips. | A rare primary bone dysplasia characterized by severe developmental delay and skeletal dysplasia (including short stature, premature carpal ossification, platyspondyly, longitudinal metaphyseal striations, and small epiphyses), as well as moderate to severe intellectual disability and facial dysmorphism, including prominent forehead, mild synophrys, depressed nasal bridge, prominent bulbous nasal tip and full lips. |
MONDO:0012503 | thiopurine S-methyltransferase deficiency | An acquired metabolic disease that is has its basis in the disruption of thiopurine S-methyltransferase activity. | An inherited metabolic disease that is has its basis in the disruption of thiopurine S-methyltransferase activity. |
MONDO:0012982 | episodic ataxia type 6 | Episodic ataxia type 6 (EA6) is an exceedingly rare form of Hereditary episodic ataxia with varying degrees of ataxia and associated findings including slurred speech, headache, confusion and hemiplegia. | Episodic ataxia type 6 (EA6) is an exceedingly rare form of hereditary episodic ataxia with varying degrees of ataxia and associated findings including slurred speech, headache, confusion and hemiplegia. |
MONDO:0013014 | spondyloepimetaphyseal dysplasia, aggrecan type | Spondyloepimetaphyseal dysplasia, aggrecan type is a new form of skeletal dysplasia characterized by severe short stature, facial dysmorphism and characteristic radiographic findings. | A spondyloepimetaphyseal dysplasia characterized by severe short stature, facial dysmorphism and characteristic radiographic findings. |
MONDO:0013233 | spondyloepimetaphyseal dysplasia, Handigodu type | Spondyloepimetaphyseal dysplasia, Handigodu type is a rare, genetic, primary bone dysplasia characterized by three distinct phenotypes, namely: 1) patients of average height with painful, osteoarthritic changes of the hip joints and no spinal abnormalities, 2) short-statured patients with predominantly truncal shortening, arm span exceeding height, dyspalstic changes of hips and varying degrees of platyspondyly, and 3) patients with dwarfism, various associated skeletal abnormalities (particularly of the knees and hands) and severe epiphyseal dysplasia (of hips, knees, hands, wrists) associated with significant platyspondyly. Most patients cannot walk long distances, and many have decreased joint spaces and sclerotic and cystic changes on imaging. | A rare, genetic, primary bone dysplasia characterized by three distinct phenotypes, namely: 1) patients of average height with painful, osteoarthritic changes of the hip joints and no spinal abnormalities, 2) short-statured patients with predominantly truncal shortening, arm span exceeding height, dyspalstic changes of hips and varying degrees of platyspondyly, and 3) patients with dwarfism, various associated skeletal abnormalities (particularly of the knees and hands) and severe epiphyseal dysplasia (of hips, knees, hands, wrists) associated with significant platyspondyly. Most patients cannot walk long distances, and many have decreased joint spaces and sclerotic and cystic changes on imaging. |
MONDO:0017754 | inborn disorder of porphyrin metabolism | An acquired metabolic disease that is has its basis in the disruption of porphyrin-containing compound metabolic process. | An inherited metabolic disease that is has its basis in the disruption of porphyrin-containing compound metabolic process. |
MONDO:0016454 | Charcot-Marie-Tooth disease type 2B5 | Charcot-Marie-Tooth disease type 2B5 is a rare axonal hereditary motor and sensory neuropathy characterized by infantile onset of slowly progressive distal motor weakness and atrophy (more severe in legs and moderate in arms) with mildly delayed motor development, hypotonia, and distal sensory impairment of all sensory modalities. | A rare axonal hereditary motor and sensory neuropathy characterized by infantile onset of slowly progressive distal motor weakness and atrophy (more severe in legs and moderate in arms) with mildly delayed motor development, hypotonia, and distal sensory impairment of all sensory modalities. |
MONDO:0016554 | neonatal iodine exposure | Neonatal iodine exposure is a rare endocrine disease characterized by the appearance of transient hypothyroidism, usually in preterm newborns, following long or short-term topical iodine exposure. Parenteral exposure from iodinated contrast agents may similarly alter thyroid funtion in term neonates. | A rare endocrine disease characterized by the appearance of transient hypothyroidism, usually in preterm newborns, following long or short-term topical iodine exposure. Parenteral exposure from iodinated contrast agents may similarly alter thyroid funtion in term neonates. |
MONDO:0018791 | Moyomoya angiopathy | A rare cerebral vasculopathy characterized by a progressive stenosis of the terminal portion of the internal carotid arteries and the development of abnormal collateral vessels. | |
MONDO:0017355 | inborn disorder of proline metabolism | An acquired metabolic disease that is has its basis in the disruption of proline metabolic process. | An inherited metabolic disease that is has its basis in the disruption of proline metabolic process. |
MONDO:0017765 | disorder of magnesium transport | An acquired metabolic disease that is has its basis in the disruption of magnesium ion transport. | An inherited metabolic disease that is has its basis in the disruption of magnesium ion transport. |
MONDO:0018121 | mitochondrial DNA maintenance syndrome | An acquired metabolic disease that is has its basis in the disruption of mitochondrial genome maintenance. | An inherited metabolic disease that is has its basis in the disruption of mitochondrial genome maintenance. |
MONDO:0018146 | idiopathic macular telangiectasia type 1 | Idiopathic macular telangiectasia type 1 is a rare, acquired, eye disease characterized by unilateral (rarely bilateral) abnormally dilated and tortuous capillaries around the fovea, associated with multiple arteriolar and venular aneurysms, lipid depositions, and intra-retinal cystoid degeneration. It leads to vision loss due to macular edema with hard exudates. | A rare, acquired, eye disease characterized by unilateral (rarely bilateral) abnormally dilated and tortuous capillaries around the fovea, associated with multiple arteriolar and venular aneurysms, lipid depositions, and intra-retinal cystoid degeneration. It leads to vision loss due to macular edema with hard exudates. |
MONDO:0018147 | idiopathic macular telangiectasia type 3 | Idiopathic macular telangiectasia type 3 is a rare, acquired, eye disease characterized by progressive visual loss, due to bilateral juxtafoveolar capillary occlusions, capillary telangiectasia, and minimal exudation. It is associated with systemic or cerebral vascular occlusive disease. | A rare, acquired, eye disease characterized by progressive visual loss, due to bilateral juxtafoveolar capillary occlusions, capillary telangiectasia, and minimal exudation. It is associated with systemic or cerebral vascular occlusive disease. |
MONDO:0018786 | pontine autosomal dominant microangiopathy with leukoencephalopathy | A rare genetic cerebral small vessel disease characterized by recurrent ischemic strokes, often with a predilection for the pons, with typical onset in the fourth or fifth decade of life. Patients present progressive cognitive and motor impairment with pyramidal, bulbar, and cerebellar symptoms, among others. Brain imaging shows multiple lacunar infarcts, typically with involvement of the pons, as well as variable leukoencephalopathy of the cerebral hemispheres. | |
MONDO:0019549 | severe early-onset axonal neuropathy due to MFN2 deficiency | Severe early-onset axonal neuropathy due to MFN2 deficiency is a rare axonal hereditary motor and sensory neuropathy characterized by early onset (<10 years) progressive distal muscle weakness and wasting of the lower limbs and later, to a lesser extent the upper limbs resulting in foot and wrist drop, areflexia, skeletal deformities (kyphoscoliosis, pes cavus with flattening, joint contractures), mild sensory impairment with vibration sense reduced to a greater extent than pain, optic atrophy and hearing loss. Wheelchair dependence by adolescence is usual and respiratory impairment with diaphragmatic paralysis may develop. | A rare axonal hereditary motor and sensory neuropathy characterized by early onset (<10 years) progressive distal muscle weakness and wasting of the lower limbs and later, to a lesser extent the upper limbs resulting in foot and wrist drop, areflexia, skeletal deformities (kyphoscoliosis, pes cavus with flattening, joint contractures), mild sensory impairment with vibration sense reduced to a greater extent than pain, optic atrophy and hearing loss. Wheelchair dependence by adolescence is usual and respiratory impairment with diaphragmatic paralysis may develop. |
MONDO:0019550 | hereditary motor and sensory neuropathy with acrodystrophy | Hereditary motor and sensory neuropathy with acrodystrophy is a rare axonal hereditary motor and sensory neuropathy characterized by progressive axonal neuropathy with limb weakness and severe distal sensory loss in all limbs and acrodystrophic changes leading to painless non-healing ulcers, osteomyelitis, contractures and mutilating lesions with loss of terminal phalanges. One family with three affected siblings is described and there have been no further descriptions in the literature since 1999. | A rare axonal hereditary motor and sensory neuropathy characterized by progressive axonal neuropathy with limb weakness and severe distal sensory loss in all limbs and acrodystrophic changes leading to painless non-healing ulcers, osteomyelitis, contractures and mutilating lesions with loss of terminal phalanges. One family with three affected siblings is described and there have been no further descriptions in the literature since 1999. |
MONDO:0019666 | spondyloepimetaphyseal dysplasia, PAPSS2 type | Spondyloepimetaphyseal dysplasia (SEMD), Pakistani type is characterized by short stature, short and bowed lower limbs, mild brachydactyly, kyphoscoliosis, abnormal gait, enlarged knee joints, precocious osteoarthropathy, and normal intelligence. | A spondyloepimetaphyseal dysplasia characterized by short stature, short and bowed lower limbs, mild brachydactyly, kyphoscoliosis, abnormal gait, enlarged knee joints, precocious osteoarthropathy, and normal intelligence. |
MONDO:0021130 | disorder of sphingolipid biosynthesis | An acquired metabolic disease that is has its basis in the disruption of sphingolipid biosynthetic process. | An inherited metabolic disease that is has its basis in the disruption of sphingolipid biosynthetic process. |
Mondo ID | Label |
---|---|
MONDO:0000218 | obsolete preimplantation embryonic lethality |
MONDO:0000601 | obsolete autoimmune disorder of urogenital tract |
MONDO:0024255 | obsolete genetic skin disease |
MONDO:0003998 | obsolete vaginal tubular adenoma |
MONDO:0004978 | obsolete aortic stenosis |
MONDO:0005410 | obsolete acute graft vs. host disease |
MONDO:0006657 | obsolete apparent mineralocorticoid excess syndrome |
MONDO:0019285 | obsolete syndromic nail anomaly |
MONDO:0019721 | obsolete syndromic renal or urinary tract malformation |
MONDO:0019117 | obsolete genetic nervous system disorder |
MONDO:0020208 | obsolete syndromic myopia |
MONDO:0015163 | obsolete primary glomerular disease |
MONDO:0008085 | obsolete neuropathy, hereditary sensorimotor, with upper motor neuron, visual pathway and autonomic disturbance |
MONDO:0008370 | obsolete reticular dystrophy of retinal pigment epithelium |
MONDO:0015953 | obsolete genetic central nervous system and retinal vascular disease |
MONDO:0020676 | obsolete disorder of central nervous system or retinal vasculature |
MONDO:0019589 | obsolete syndromic genetic hearing loss |
MONDO:0019833 | obsolete pituitary hormone deficiency from tumoral origin |
MONDO:0043007 | obsolete genetic multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome |
MONDO:0009827 | obsolete pachyonychia congenita, autosomal recessive |
MONDO:0019282 | obsolete syndromic hair shaft abnormality |
MONDO:0019058 | obsolete neurometabolic disease |
MONDO:0014783 | obsolete preimplantation embryonic lethality 1 |
MONDO:0018609 | obsolete syndromic hereditary optic neuropathy |
MONDO:0014978 | obsolete preimplantation embryonic lethality 2 |
MONDO:0043008 | obsolete genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability |
MONDO:0016110 | obsolete non-dystrophic myopathy |
MONDO:0017143 | obsolete genetic infertility |
MONDO:0018787 | obsolete genetic cerebral small vessel disease |
MONDO:0019843 | obsolete pituitary hormone deficiency secondary to a granulomatous disease |
MONDO:0019601 | obsolete autosomal recessive axonal hereditary motor and sensory neuropathy |
MONDO:0019834 | obsolete pituitary hormone deficiency from meningeal origin |
MONDO:0019841 | obsolete pituitary hormone defiency from vascular origin |
MONDO:0020225 | obsolete syndromic cataract |
MONDO:0020503 | obsolete resistance to thyrotropin-releasing hormone syndrome |
MONDO:0021027 | obsolete genetic hair anomaly |
MONDO:0021028 | obsolete genetic nail anomaly |
MONDO:0022018 | obsolete Borrone di Rocco Crovato syndrome |
MONDO:0022620 | obsolete CD4 deficiency |
MONDO:0022880 | obsolete corticobasal degeneration |
MONDO:0043005 | obsolete genetic multiple congenital anomalies/dysmorphic syndrome |
MONDO:0044331 | obsolete genetic transient congenital hypothyroidism |
Mondo ID | Label |
---|---|
MONDO:0006051 | postweaning multisystemic wasting syndrome |
MONDO:0009579 | Frank-Ter Haar syndrome |
MONDO:0025155 | hemorrhagic syndrome, bovine |
MONDO:0034104 | global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome |
MONDO:0100282 | SC phocomelia syndrome |
Mondo ID | Label |
---|---|
MONDO:0016156 | qualitative or quantitative defects of FKRP |
MONDO:0016184 | qualitative or quantitative defects of protein O-mannosyltransferase 1 |
MONDO:0016185 | qualitative or quantitative defects of protein O-mannosyltransferase 2 |
MONDO:0042981 | aortic valve stenosis |
MONDO:0016195 | qualitative or quantitative defects of beta-myosin heavy chain (MYH7) |
MONDO:0016187 | qualitative or quantitative defects of desmin |
MONDO:0016151 | qualitative or quantitative defects of perlecan |
MONDO:0016198 | qualitative or quantitative defects of plectin |
MONDO:0016152 | qualitative or quantitative defects of calpain |
MONDO:0016145 | qualitative or quantitative defects of dysferlin |
MONDO:0016143 | qualitative or quantitative defects of gamma-sarcoglycan |
MONDO:0016153 | qualitative or quantitative defects of TRIM32 |
MONDO:0016193 | qualitative or quantitative defects of alpha-actin |
MONDO:0016197 | qualitative or quantitative defects of selenoprotein N1 |
MONDO:0017303 | qualitative or quantitative defects of tropomyosin |
MONDO:0016147 | qualitative or quantitative defects of dystrophin |
MONDO:0016196 | qualitative or quantitative defects of emerin |
MONDO:0016154 | qualitative or quantitative defects of myotubularin |
MONDO:0016199 | qualitative or quantitative defects of protein SERCA1 |
MONDO:0016144 | qualitative or quantitative defects of delta-sarcoglycan |
MONDO:0016192 | qualitative or quantitative defects of telethonin |
MONDO:0016191 | qualitative or quantitative defects of titin |
MONDO:0016142 | qualitative or quantitative defects of beta-sarcoglycan |
MONDO:0017302 | qualitative or quantitative defects of troponin |
MONDO:0016200 | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
MONDO:0016141 | qualitative or quantitative defects of alpha-sarcoglycan |
MONDO:0016201 | qualitative or quantitative defects of myotilin |
MONDO:0016190 | qualitative or quantitative defects of protein ZASP |
MONDO:0016189 | qualitative or quantitative defects of filamin C |
MONDO:0016150 | qualitative or quantitative defects of integrin alpha-7 |
MONDO:0016155 | qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan |
MONDO:0018529 | qualitative or quantitative defects of Torsin-1A-interacting protein 1 |
MONDO:0016194 | qualitative or quantitative defects of nebulin |
MONDO:0016139 | qualitative or quantitative protein defects in neuromuscular diseases |
MONDO:0016140 | sarcoglycanopathy |
MONDO:0016149 | qualitative or quantitative defects of merosin |
MONDO:0018282 | qualitative or quantitative defects of alpha-dystroglycan |
MONDO:0016157 | qualitative or quantitative defects of fukutin |
MONDO:0016182 | qualitative or quantitative defects of protein O-mannose beta1, 2N-acetylglucosaminyltransferase |
MONDO:0016183 | qualitative or quantitative defects of protein glycosyltransferase-like |
MONDO:0016186 | qualitative or quantitative defects of myofibrillar proteins |
MONDO:0016188 | qualitative or quantitative defects of alphaB-cristallin |
MONDO:0018283 | primary qualitative or quantitative defects of alpha-dystroglycan |
Files
monarch-initiative/mondo-v2022-09-06.zip
Files
(67.1 MB)
Name | Size | Download all |
---|---|---|
md5:a1c2b81cdd8d299f6c23a6b5f70bbf05
|
67.1 MB | Preview Download |
Additional details
Related works
- Is supplement to
- https://github.com/monarch-initiative/mondo/tree/v2022-09-06 (URL)